Patient-requested surveillance for suspected acral melanoma: balancing autonomy and clinical risk

Clicks: 6
ID: 323230
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #28 of 169 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 169 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
We present an ethical dilemma involving a patient with suspected acral melanoma who requests surveillance rather than the recommended urgent excision biopsy. This raises a conflict between respect for patient autonomy and the need for timely investigation of a potentially serious malignancy. The case explores how clinicians should respond when a capacitous patient declines recommended cancer pathway management.
Reference Key
openalex_W7172206251 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sumbel Khan, Neil P Patel
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag341
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.